EUVIMEDEUVIMED entdecken
Crossref

Characterization of Ganciclovir Dosing for the Management of Cytomegalovirus in Solid Organ Transplant Recipients Receiving Sustained Low-Efficiency Dialysis

Jinfan Aaron Zhang iD, Paula Brown, Jennifer Harrison, Marisa Battistella iD

Annals of Pharmacotherapy · 2025

DOI: 10.1177/10600280241283966 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Pharmacotherapy, 2025. Verfasst von Jinfan Aaron Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Michael Garron Hospital, Toronto East Health Network, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Ganciclovir, Cytomegalovirus Infections, Antiviral Agents, Renal Dialysis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The optimal dosing of intravenous ganciclovir in patients receiving sustained low-efficiency dialysis (SLED) remains unclear.

Objective

The primary objective is to characterize the dosing of ganciclovir for treating and preventing cytomegalovirus (CMV) in Solid Organ Transplant Recipients receiving SLED. The secondary objective is to evaluate the safety and efficacy of the dosing practices described in this study.

Methods

Retrospective review of electronic medical records from solid organ transplant recipients (SOTRs) admitted to the Medical Surgical Intensive Care Unit at the Toronto General Hospital (TGH) between November 28, 2016, and September 1, 2021, was conducted. Patients concurrently receiving ganciclovir and SLED were included.

Results

Among the 27 encounters for CMV prevention, 18 patients underwent 8-hour SLED, 6 underwent 24-hour SLED, and 3 received other SLED durations. Most patients (80%) on 8-hour SLED began ganciclovir at 2.5 mg/kg/d, whereas 80% of those on 24-hour SLED started at 5 mg/kg/d. No breakthrough viremia occurred at 5 mg/kg/d, with 1 instance at 2.5 mg/kg/d. Cytopenia rates were higher at 5 mg/kg/d (33% vs 20%). For treatment (n = 20), 16 patients underwent 8-hour SLED, 2 underwent 24-hour SLED, and 2 underwent 12-hour SLED. Most (75%) on 8-hour SLED started at 2.5 mg/kg/d, whereas all on 24-hour SLED began at 5 mg/kg/d. Viral eradication rates were 75% and 60% at 2.5 and 5 mg/kg/d, respectively, with higher cytopenia rates at 5 mg/kg/d (37.5% vs 0%). Dose adjustments were primarily in response to refractory disease or cytopenia. Conclusion and Relevance: At our institution, ganciclovir dosing patterns suggest that for patients requiring 8-hour SLED, there is clinician comfort in using 2.5 mg/kg/d for prevention and 5 mg/kg/d for treatment. In 24-hour SLED, 5 mg/kg/d may be considered for prevention. Higher doses may be considered for CMV treatment; however, we found greater variability in the dosing practices for these patients. Further research with larger sample sizes and ganciclovir drug-level assessments is needed to optimize dosing strategies for CMV treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GanciclovirCytomegalovirus InfectionsAntiviral AgentsRenal DialysisOrgan TransplantationHumansRetrospective StudiesFemaleMaleMiddle AgedAgedTransplant RecipientsAdultDose-Response Relationship, DrugCytomegalovirus

Stichwörter der Autor:innen

antiviralclinical pharmacologyclinical pharmacyclinical practicecytomegalovirusdialysispharmaceutical caretransplant

Substanzen

GanciclovirAntiviral Agents

Autor:innen und Institutionen

  • Michael Garron Hospital, Toronto East Health Network, Toronto, Ontario, Canada.
  • University Health Network, Toronto, Ontario, Canada.

ORCID-Profile: Jinfan Aaron Zhang, Marisa Battistella

Zitieren

APA

Zhang, J. A., Brown, P., Harrison, J., & Battistella, M. (2025). Characterization of Ganciclovir Dosing for the Management of Cytomegalovirus in Solid Organ Transplant Recipients Receiving Sustained Low-Efficiency Dialysis. Annals of Pharmacotherapy. https://doi.org/10.1177/10600280241283966

Vancouver

Zhang JA, Brown P, Harrison J, Battistella M. Characterization of Ganciclovir Dosing for the Management of Cytomegalovirus in Solid Organ Transplant Recipients Receiving Sustained Low-Efficiency Dialysis. Annals of Pharmacotherapy. 2025. doi:10.1177/10600280241283966

BibTeX
@article{Zhang2025,
  author = {Zhang, Jinfan Aaron and Brown, Paula and Harrison, Jennifer and Battistella, Marisa},
  title = {Characterization of Ganciclovir Dosing for the Management of Cytomegalovirus in Solid Organ Transplant Recipients Receiving Sustained Low-Efficiency Dialysis},
  journal = {Annals of Pharmacotherapy},
  year = {2025},
  doi = {10.1177/10600280241283966}
}
Kostenlos starten →